B-cell subsets in blood and lymphoid organs in Macaca fascicularis

Cytometry Part A

Volumn 61, Issue 1, 2004, Pages 69-75

  Vugmeyster, Yulia ^a   Howell, K ^a   Bakshi, A ^a   Flores, C ^a   Hwang, O ^a   McKeever, K ^a  

^a GENENTECH INC   (United States)

Author keywords

B cell subsets; B cell targeting; Macaca fascicularis

Indexed keywords

B7 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD27 ANTIGEN; CD32 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN M;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BLOOD; BLOOD SAMPLING; BONE MARROW; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL SUBPOPULATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IN VIVO STUDY; INFECTION; LYMPH NODE; LYMPHOID ORGAN; MACACA; MONKEY; NONHUMAN; PHENOTYPE; PRIMATE; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; CELL SEPARATION; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE SUBSETS; LYMPHOID TISSUE; MACACA FASCICULARIS;

EID: 4444273697     PISSN: 15524922     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.a.20039     Document Type: Article

References (24)

1. + lymphocytes in cynomolgus monkeys are of resting memory T lineage. Int Immunol 1997;9:591-597.
2. Lappin PB, Black LE. Immune modulator studies in primates: the utility of flow cytometry and immunohistochemistry in the identification and characterization of immunotoxicity. Toxicol Pathol 2003;31(suppl):111-118.
3. Buse E, Habermann G, Osterburg I, Korte R, Weinbauer GF. Reproductive/developmental toxicity and immunotoxicity assessment in the nonhuman primate model. Toxicology 2003;185:221-227.
4. - T cells in cynomolgus monkeys. Int Immunol 2000;12:1095-1103.
5. Poaty-Mavoungou V, Onanga R, Yaba P, Delicat A, Dubreuil G, et al. Comparative analysis of natural killer cell activity, lymphoproliferation and lymphocyte surface antigen expression in nonhuman primates housed at the CIRMF Primate Center, Gabon. J Med Primatol 2001;30:26-35.
6. Liu YJ, Arpin C. Germinal center development. Immunol Rev 1997;156:111-126.
7. Liu YJ, Arpin C, de Bouteiller O, Guret C, Banchereau J, et al. Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development. Semin Immunol 1996;8:169-177.
8. Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol 2002;2:323-335.
9. Du MQ, Peng HZ, Dogan A, Diss TC, Liu H, et al. Preferential dissemination of B-cell gastric mucosa-associated lymphoid tissue (MALT) lymphoma to the splenic marginal zone. Blood 1997;90:4071-4077.
10. Tangye SG, Liu YJ, Aversa G, Phillips JH, de Vries JE. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med 1998;188:1691-1703.
11. Vugmeyster Y, Howell K, Bakshl A, Flores C, Canova-Davis E. Effect of anti-CD20 monoclonal antibody, Rituxan, on cynomolgus monkey and human B cells in a whole blood matrix. Cytometry 2003;52A:101-109.
12. Mackay F, Schneider P, Rennert P, Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 2003;21:231-264.
13. Macardle PJ, Mardell C, Bailey S, Wheatland L, Ho A, et al. Fcgam-maRIIb expression on human germinal center B lymphocytes. Eur J Immunol 2002;32:3736-3744.
14. Avery DT, Kalled SL, Ellyard JI, Ambrose C, Bixler SA, et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest 2003;112:286-297.
15. Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994;83:435-445.
16. Schroder C, Azimzadeh AM, Wu G, Price JO, Atkinson JB, et al. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys. Transpl Immunol 2003;12:19-28.
17. Sopper S, Stahl-Hennig C, Demuth M, Johnston IC, Dorries R, et al. Lymphocyte subsets and expression of differentiation markers in blood and lymphoid organs of rhesus monkeys. Cytometry 1997;29:351-362.
18. Fernandez-Gutierrez B, Hernandez-Garcia C, Banares AA, Jover JA. CD23 hyperexpression in rheumatoid arthritis: evidence for a B cell hyperresponsiveness to cognate and noncognate T-cell signals. Clin Immunol Immunopathol 1994;72:321-327.
19. Erkeller-Yuksel FM, Deneys V, Yuksel B, Hannet I, Hulstaert F, et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr 1992;120(2 Pt 1):216-222.
20. Burkly LC. CD40 pathway blockade as an approach to immunotherapy. Adv Exp Med Biol 2001;489:135-152.
21. Kalled SL, Ambrose C, Hsu YM. BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders. Expert Opin Ther Targets 2003;7:115-123.
22. Pelletier M, Thompson JS, Qian F, Bixler SA, Gong D, et al. Comparison of soluble decoy IgG fusion proteins of BAFF-R and BCMA as antagonists for BAFF. J Biol Chem 2003;278:33127-33133.
23. Vugmeyster Y, Howell K, McKeever K, Combs D, Canova-Davis E. Differential in vivo effects of rituximab on two B-cell subsets in cynomolgus monkeys. Int Immunopharmacol 2003;3:1477-1481.
24. Gopal AK, Press OW. Clinical applications of anti-CD20 antibodies. J Lab Clin Med 1999;134:445-450.